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We studied npolipoprotein D (apoD) mRNA in primary cultures of human diploid fibroblasts (HDF). In early-passage HDF no apoD mRNA 
was detected in replicating sells in sparse culture. but the gene was expressed in quiescent cells in confluent and in serum-starved cultures. In contrast, 
late-passage HDF expressed apoD mRNA in sparse culture, but the level increased after attainment of confluence. Thus fibroblasts, the common 
cell-type expressing apoD mRNA in vivo. express this characteristic following growth-arrest. The same pattern of activation was found in another 
fibroblast cell line deficient in apoB/E (LDL) receptors, excluding a role for cellular cholesterol delivery by the LDL-receptor pathway controlling 
apoD expression 
Lipocalin (a2u-globulin) family; Growth arrest 
1. INTRODUCTION proliferation to 50% whereas estrogens had opposite 
effects on both parameters [21]. 
Apoliprotein D (apoD) is a glycoprotein of M, 29 000 
found mainly on the high density plasma lipoproteins 
(HDE) of man [I-6], baboon [7], rabbit and other 
species [$I. ApoD is an atypical apolipoprotein, 
nevertheless. The cloning and sequencing of the human 
cDNA revealed that it belongs to the Lipocalin (&!u- 
globulin) family [3,9]. Proteins in this family transport 
specific hydrophobic ligands (lipids) in a one-to-one 
molar ratio in a ligand-binding pocket composed of 
antiparallel /?-strands [lo-161. The apoD gene is ex- 
pressed in all 16 rabbit organs that we analysed [8] and 
many peripheral organs in man [3]. Being expressed 
mainly in peripheral organs such as spleen, lung, 
adrenal gland, central nervous system and male genital 
tissues, rather than liver and small intestine,it is unlike 
all other apolipoproteins. ApoD gene expression was 
found mainly in interstitial and connective tissue fi- 
broblasts, with higher levels often near blood vessels, 
using in situ hybridization techniques with rhesus [17] 
and rabbit organs [29]. 
However, given that the cells that express apoD most 
often in vivo appear to be fibroblasts, we studied apoD 
mRNA levels in normal human diploid fibroblasts 
(HDF) in primary culture. We show here that apoD 
mRNA was detectable only in nonproliferating quie- 
scent and senescent cultures, and that apoD expression 
was independent of exogenous cholesterol in this cell 
model. 
2. MATERIALS AND METHODS 
2.1. Cd cultures 
ApoD expression appears to be modulated in vivo: 
the protein increased over 500-fold in regenerating rat 
sciatic nerves [I X-201. Addition of androgens to human 
breast cancer cells in culture both stimulated apoD 
(GCDFP-24) secretion 3- to 4-fold and decreased cell 
A human diploid fibroblast strain (HDF-I) (gift from Dr S. Lussier- 
Cacan, Institut dc Recherches Cliniqucs de Montrbal) was cultured 
from a skin biopsy from a 26-year-old man. We found that its in vitro 
life span before phase-out was about 56 population doubling levels 
(PDLs) [22]. Early- and late-passage cultures. at about 21 and 42 
PDLs, had growth rates of 34 or 80 h per PDL, respectively. At least 
30% of cells in the late-passage but none in the early passage culture 
had signs of senescence - large cytoplasm and nucleus [23]. A homo- 
zygous B/E receptor (LDL-receptor) deficient fibroblast strain (HFH) 
was obtained from the NIGMS Human Genetic Mutant Cell Repo- 
sitory (Camden, N.J,, repository number GMl9lS). The PDLs of this 
culture were unknown but no cells had senescent morphology. 
All cells were maintained at 37OC in Eagle’s Minimum Essential 
Medium supplcmcntcd with 10% fetal bovine serum and 1% nonessen- 
tial amino acids. The levels of apoD gene expression seemed to vary 
from one serum batch to anoi;ler but the pattern of gene expression 
remained the same. 
A6hwinriort.s; HDF, human diploid fibroblast; PDLs, population 
doubling levels; GCDFP, gross-cystic-disease-fluid protein, 
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Sparse cultures were plated at 8.5 x IO” cells/cm2, cultured for about 
48 h, then trypsinized and frozen in liquid NL. Confluent cultures were 
initially plated at 2.5 x IO4 cells/cm2 and medium was renewed every 
48 h until they attained confluence (estimated using the microscope) 
designated’dayo post-confluence’ at that time. Generally medium was 
not renewed for these ceils, except where indicated, until trypsinitation 
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Total RNA was extracted by the acidjguanidium thiocyanatc/phe- 
nolkhtoroform method 1241 from 2-3 x IO6 frozen cells. RNA concen- 
tration was measured by spectrophotometry [25]. Glyoxal-denatured 
RNA was electrophoresed in I .I% aparose gel and transferred to 
Nytran membranes which were hybridized atGO”C [26]. The DNA 
probes were prepared by the random-primed oligonucleotide method 
[27] using the 800.bp EcoRl fragment purified From the pAPOD 
clone provided by Dr D. Drayna, Genentech Inc. [3]. After hybridiza- 
tion the membranes were washed in 2 x SET for 1 min at room 
temperature, 2 x SET containing 0.2% SDS at 60°C for 30 min, 1 x 
SET containing 0.2% SDS at 60°C for 30 min, and finally I x SET 
for I min at room temperature. 1 x SET contained 30 mM Tris-HC1, 
pW 7.4, 1.50 mM NaCI, 2 mM EDTA. After exposure, the probe was 
removed by washing with 18 mM NaCI, 0. I mM EDTA, 1 mM sodium 
phosphate pH 7,0.1% SDS, at 80°C for 10 min. and then rehybridized 
with X2P-labclled actin cDNA probe or 32P-labelled c-j& cDNA probe 
as indicated. 
3. RESULTS AND DISCUSSION 
The analysis of early-passage normal fibroblasts (21 
PDLs) revealed detectable mRNA only after attaining 
confluence (Fig. 1). No message was seen in replicating 
sparse culture nor in the extract isolated on the same 
day when oonfluence of the culture was attained. 
Growth arrest at confluence was confirmed by a second 
hybridization of the same filter with the 32P-labelled 
C--OS cDNA probe, and finding reduced expression of 
The same experiment was performed in parallel with 
late-passage normal fibroblasts (42 PDLs) of the same 
this oncogene [28] when compared to the replicating 
strain, that unlike the early-passage cells showed signs 
of senescence. In contrast to the early-passage cells the 
sparse culture (data not shown). ApoD mRNA was 
late-passage sparse cultures expressed apoD mRNA 
even with 10% serum supplementation (Fig. l), but the 
found in sparse culture when we used serum-starvation 
level nevertheless increased after attainment of con- 
fluence, reaching a peak 2 days later. The subsequent 
to induce growth-arrest (Fig. l), but not in the replica- 
decrease in late-passage cells 4 and 14 days post-con- 
fluence, and the low level of apoD mRNA in the 7-day 
ting sparse cells, showing that establishment of con- 
serum-starved sparse culture, could be due to cell death. 
A decrease of c-f0.s mRNA levels is characteristic of 
fluence itself is not essential for activation of the apoD 
senescent cultures [28]. The hybridization of t.he c-fos- 
cDNA probe was lower in the late- than in the early- 
gene. 
passage sparse cells (not shown). In our experiments, 
c-fos expression decreased further after confluence in 
late-passage cultures (data not shown). ‘Thus, apoD 
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and Freezing 0, 2, 7, or 14 days post-confluence. Serum-starved fi- 
broblasts were initially plated as a sparse culture in 10% fetal calf- 
serum supplemented medium, which was changed to 0.5% fetal bovine 
serum about 24 h after plating. This 0.5% serum medium was replaced 
with fresh medium 48 h later, and the starved cells maintained in 
culture For 3 and 7 days. The growth state of some of the cultures was 
estimated by Northern blot analysis with a 32P-labelled c-fos DNA 
probe. 
2.2. mRNA analysis 
Fig. 1. Northern blot analysis ofapoD mRNA levels in normal human 
diploid Ftbroblasts in early- and late-passage cultures. Totat RNA (15 
c(g) extracted from various samples of the HDF-I cell strain were 
analysed by Northern blot. The filter was hybridized with 32P-labelled 
APODG cDNA, washed, and autoradiographed (16 h exposure). The 
early- and late-passage cultures had PDLs of 21 and 42 respectively. 
Sp. non-serum starved sparse cultures; C. cell cultures harvested by 
the day of confluence cstsblishment; 2, 7. and 14. day-2, day-7 and 
day-14 post-confluence; SS, serum starved sparse cultures analysed 
after 7 days of starvation. 
gene expression in normal human diploid fibroblasts is 
most likely specific to growth arrest and senescence in 
culture. 
The medium was not renewed following confluence 
in the confluent cultures assayed in Fig. 1. Therefore, 
expression of the apoD mRNA could have occurred 
following the degradation of a potential inhibitor in the 
medium. However, the specific activation of the apoD 
gene in confluent cultures was observed in a subsequent 
experiment when the medium was changed every 2 days 
(data not shown). Thus, it appeared that neither the 
starvation of a particular component, nor incubation in 
conditioned medium was likely to have induced apoD 
mRNA expression. The expression in the sparse culture 
of late-passage cells (Fig. 1) was clearly not linked to 
degradation of a compound in the medium because this 
medium had been renewed every 2 days until cell har- 
We could not exclude that the expression seen in Fig. 
vest. 
1 was not induced by the accumulation of a gene activa- 
tor coming from the degradation of dead sells in the 
culture and so we tested that hypothesis with the fol- 
lowing experiment. A replicating sparse culture (3 x lo6 
cells/350 cm*) of early-passage HDF was incubated in 
complete medium to which we added cellular debris 
prepared by freezing, thawing and vortexing an identi- 
cal culture. In a second experiment we added cholesterol 
(20 pg/ml) to a culture. No apoD mRNA was detected 
in either experiment after 2 days culture, before con- 
fluence was reached (data not shown), although 2 days 
sufficed for induction of apoD in confluent cells (Fig. 
1). Therefore, we do not believe that either free choleste- 
rol or cell debris was an inducer of apoD in our fibro- 
blast cuhures. It is more difficult to exclude the idea that 
the apoD gene was activated in cells undergoing a pro- 
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Fig. 2. Northern blot analysis of apoD mRNA levels in cells of the 
apoE?/E (LDL)-receptor deficient fibroblastic strain (HDF). Total 
RNA (15 ,!~g) extracted from various samples of the HFH sell strain 
were analysed by Northern blot. The filter was hybridized subsequent- 
ly with APODG and actin cDNA-probes as indicated. Eoth autora- 
diographs were exposed for I6 h. Sp. non-serum starved sparse cultu- 
res; C2, 7, and 14, day-2, day-7 and day-14 post-confluence. 
IXSS leading to cell death. But against this idea we did 
not detect any apoD mRNA in replicating sparse cultu- 
res of early-passage cells, despite there being 2-5% dead 
cells staining with Trypan blue, in these cultures. Thus 
apoD expression in these cultures was probably not 
linked to cell death. 
The specific expression of apoD mRNA in nonproli- 
ferating quiescent fibrobla.st cultures was observed with 
two other strains of human fibroblasts, both having 
homozygous mutations affecting the B/E (LDL) recep- 
tor gene (Fig. 2 and further data not shown). Therefore, 
control of apoD mRNA expression does not seem to be 
related to the activity of the LDL-receptor pathway of 
cholesterol metabolism. 
Soon after reaching confluence early-passage cells 
had no detectable apoD mRNA (sample C, Fig. l), 
whereas the c-fos mRNA level was significantly lower 
in this sample than in the replacing sparse culture. These 
results together with the observation of a continued rise 
in apoD mRNA until 14 days post-confluence in this 
culture indicate that the induction of apoD transcrip- 
tion was probably a consequence of growth arrest. The 
biochemical stimulus, mechanism and function of this 
induction are still unknown. We could postulate that 
apoD plays a role in cellular homeostasis, required only 
under some metabolic conditions that occur following 
growth arrest, or that expression of apoD is a marker 
of the induction of fibroblasts into a particular func- 
tional state. The finding of high levels of apoD mRNA 
and protein in endoneurial fibroblasts during nerve re- 
generation [19,20] fsvours the hypothesis that exoge- 
nous factors may induce the expression of apoD and 
that fibroblasts that express it have developed a new 
function or activity. 
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